Register entry
Sichuan Xieli Pharmaceutical Co Ltd
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 6
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Active ingredient (API) manufacture1Finished drug manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Sichuan Xieli Pharmaceutical Co Ltd | NO. 588, MIDDLE SECTION OF MUDAN AVENUE, TIANPENG TOWN, Pengzhou, Sichuan 611930, China (CHN) | Active ingredient (API) manufacture, Finished drug manufacture | 3007432586529534612 |
Catalogue
Drug listings by form and route
66 active NDC listings: 6 bulk ingredient. By marketing category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 6.
| Dosage form | NDCs |
|---|---|
| powder, for suspension | 6 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| sichuan xieli pharmaceutical co., ltd. | 6 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Anastrozole | powder, for suspension | 61200-104BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Cabazitaxel | powder, for suspension | 61200-101BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | DASATINIB MONOLAURYL SULFATE | powder, for suspension | 61200-106BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Erlotinib Hydrochloride | powder, for suspension | 61200-013BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Irinotecan Hydrochloride | powder, for suspension | 61200-112BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | URSODIOL | powder, for suspension | 61200-001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Compare
Comparable companies in China
- Kingkey MBC Life Technology Group co., LTD.1 site · 158 NDC
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Zhejiang Guoyao Jingyue Aerosol Co Ltd1 site · 94 NDC
- Shenzhen iShan Technology Co Ltd1 site · 84 NDC
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.1 site · 68 NDC
- Changzhou Maokang Medical Products Co., Ltd1 site · 59 NDC
- Jianerkang Medical Co Ltd1 site · 56 NDC
- Zhejiang Ausun Pharmaceutical Co., Ltd.1 site · 55 NDC
- Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd1 site · 40 NDC
- Guangdong Aimu Biological Technology Co Ltd1 site · 39 NDC
Enquiry
Common questions
- Is Sichuan Xieli Pharmaceutical Co Ltd FDA approved?
- Sichuan Xieli Pharmaceutical Co Ltd holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Sichuan Xieli Pharmaceutical Co Ltd's drugs manufactured?
- The FDA register lists Pengzhou. Registered operations: active ingredient (API) manufacture, finished drug manufacture.
- What drugs does Sichuan Xieli Pharmaceutical Co Ltd make?
- 6 products are listed under Sichuan Xieli Pharmaceutical Co Ltd in the openFDA NDC Directory, most often as powder, for suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.